CASI Pharmaceuticals, Inc. (CASIF)
OTCMKTS
· Delayed Price · Currency is USD
0.132
0.00 (0.00%)
At close: Apr 28, 2026
CASI Pharmaceuticals Market Cap
CASI Pharmaceuticals has a market cap or net worth of $2.71 million as of April 29, 2026. Its market cap has decreased by -91.02% in one year.
Market Cap
2.71M
Enterprise Value
16.88M
Revenue
26.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.13
Market Cap Chart
Since June 12, 1996, CASI Pharmaceuticals's market cap has decreased from 101.76M to 2.71M, a decrease of -97.33%. That is a compound annual growth rate of -11.42%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaccinex | 2.81M |
| VitaSpring Biomedical | 2.30M |
| AXIM Biotechnologies | 2.22M |
| ProtoKinetix | 2.21M |
| Avenue Therapeutics | 2.17M |
| Oncology Pharma | 3.48M |
| Enzolytics | 1.93M |
| Bioxytran | 3.97M |